Shares of Orexigen tanked after they revealed they are halting work on FDA approval of their anti-obesity drug Contrave.
http://finance.yahoo.com/news/Orexigen-puts-obesity-drug-apf-2428062223.html?x=0&.v=3
Friday, June 3, 2011
Subscribe to:
Post Comments (Atom)
Posts
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v1do105DMxriTRmRsSlKdBaH1ukzCzV69rTJxW8IzZIzwnnXRWXPBmHdXbn5J-8LDSGJMyd-SmENJASmD3tUUDXuwkwLB1phXoMZFN1jV6aQr8-GTVaubnbopwUlruo04Lvw=s0-d)
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sjcFkgPwxByp6tJAtk0D3FK0_VixlbZ6CMoCXM0rOaLfSjlnGqxZQZgwCCuIjYBaZPlbAxwDdwKZfp96Ap4ytDMAc_sjhagXAgpHVXkH4LYIWMXwF_zNux4LKBfWJ-T2htn2UM=s0-d)
![[Most Recent USD from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vrCZYYurnKc1IdlJnwBkZLBGC7QUpSTV3zApLhu9lfzZQ1DLEYAfjrqmwn41t0KCdqxL_5RuHr5YLs_xVTSM5f5oLIzSNsKbdCGcdkjRQIm4UKns6gNxux=s0-d)
No comments:
Post a Comment